Rhode Island 2025 Regular Session Status: In Committee 10 D cosponsors

SB 486 — AN ACT RELATING TO STATE AFFAIRS AND GOVERNMENT -- THE RHODE ISLAND HEALTH CARE REFORM ACT OF 2004 -- HEALTH INSURANCE OVERSIGHT

Last action — 03/20/2025 Committee recommended measure be held for further study

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 486 on the official Rhode Island source →

Action History

  1. 03/20/2025 Committee recommended measure be held for further study

  2. 03/14/2025 Scheduled for hearing and/or consideration (03/20/2025)

  3. 02/26/2025 Introduced, referred to Senate Health and Human Services

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

10 sponsors · 0 co-sponsors · 104 not signed on

Sponsors (10)

Co-sponsors (0)

None.

Not signed on (104)

104 members have not signed on to this bill.

Show all 104 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passage

Passed 37 Yea · 0 Nay
Party YeaNayPresentNot Voting
Democratic 27000
Unaffiliated 7000
Republican 3000
Total 37000
% of votes cast 100%0%0%0%
How each member voted (37)
Member Party Vote
Cano — Yea
DeLuca — Yea
Lombardo — Yea
Miller — Yea
Picard — Yea
Mr. President — Yea
de la Cruz — Yea
Alana M. DiMario Democratic Yea
Ana B. Quezada Democratic Yea
Bridget Valverde Democratic Yea
David P. Tikoian Democratic Yea
Dawn Euer Democratic Yea
Frank A. Ciccone III Democratic Yea
Hanna M. Gallo Democratic Yea
John J. Lombardi Democratic Yea
John P. Burke Democratic Yea
Jonathon Acosta Democratic Yea
Leonidas P. Raptakis Democratic Yea
Linda L. Ujifusa Democratic Yea
Louis P. DiPalma Democratic Yea
Mark McKenney Democratic Yea
Matthew L. LaMountain Democratic Yea
Meghan E. Kallman Democratic Yea
Melissa Murray Democratic Yea
Pamela J. Lauria Democratic Yea
Robert Britto Democratic Yea
Ryan W. Pearson Democratic Yea
Samuel D. Zurier Democratic Yea
Samuel W. Bell Democratic Yea
Tiara T. Mack Democratic Yea
V. Susan Sosnowski Democratic Yea
Valarie J. Lawson Democratic Yea
Victoria Gu Democratic Yea
Walter S. Felag Jr. Democratic Yea
Elaine J. Morgan Republican Yea
Gordon E. Rogers Republican Yea
Thomas J. Paolino Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 486 do?
Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.
Who sponsors SB 486?
SB 486 is sponsored by Lori Urso (Democratic), Peter A. Appollonio Jr. (Democratic), Linda L. Ujifusa (Democratic), Hanna M. Gallo (Democratic), Ryan W. Pearson (Democratic), V. Susan Sosnowski (Democratic), Bridget Valverde (Democratic), Melissa Murray (Democratic), Louis P. DiPalma (Democratic), and Pamela J. Lauria (Democratic).
What is the current status of SB 486?
This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 486?
Track SB 486 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 486

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 486

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →